SYNLAB AG (SYAB.F)

10.52 -0.10 (-0.94%) As of 08:05AM CEST. Market open.

SYNLAB AG

Moosacher Straße 88
Munich 80809
Germany
49 89 307602 0
https://www.synlab.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 23,538

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mathieu Floreani	Chairman of the Management Board & CEO	2.39M	N/A	1967
Dr. Bartholomäus Wimmer	Founder & Independent Member of the Supervisory Board	132k	N/A	1962
Mr. Sami Badarani	CFO & Member of Management Board	1.5M	N/A	1963
Mr. Robert Steinwander	Group Chief Operating Officer	N/A	N/A	N/A
Mr. Henrik Andreasen	Group Chief Information Officer	N/A	N/A	N/A
Dr. Anna Niedl	Head of Investor Relations	N/A	N/A	N/A
Ms. Kimberly Urdahl	Group General Counsel & Group Chief Compliance Officer	N/A	N/A	N/A
Alexander Hagen	Group Head of Commercial & Marketing	N/A	N/A	N/A
Ms. Catharina Monster	Group Chief Human Resources Officer	N/A	N/A	N/A
Mr. Luis Vieira	Group Chief Strategy Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

Corporate governance

SYNLAB AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.